{"artifact":{"id":"bench_neurodegeneration_drug_target_druggability_v1","artifact_type":"benchmark","entity_ids":"bench_neurodegeneration_drug_target_druggability_v1","title":"Neurodegeneration Drug Target Druggability","quality_score":0.82,"created_by":"codex:52","provenance_chain":"[{\"source\": \"forge:benchmark_seed_2026-04-28\", \"task_id\": \"1186a9ab-ebf2-4a5b-84f1-27241b6631d3\"}]","content_hash":"3e76d6ec30fda4e6ece31fdba962e8b3298cc504fb9eb6f8e0747e18fab3695e","metadata":{"task_id":"1186a9ab-ebf2-4a5b-84f1-27241b6631d3","wiki_path":"/wiki/forge/benchmarks/neurodegeneration-drug-target-druggability","provenance":"forge:benchmark_seed_2026-04-28","description":"Regression benchmark for druggability of the top 100 neurodegeneration KG entities using structural, ligandability, and tractability evidence.","content_json":{"id":"bench_neurodegeneration_drug_target_druggability_v1","slug":"neurodegeneration-drug-target-druggability","task":{"input":"SciDEX KG entity id or HGNC symbol","split":"entity-type-stratified 80/20 split; protein families grouped in the same fold","output":"Continuous druggability score in [0, 1]","label_space":"real-valued"},"title":"Neurodegeneration Drug Target Druggability","metric":"spearman","task_id":"1186a9ab-ebf2-4a5b-84f1-27241b6631d3","version":"v1","evaluation":{"leakage_guard":"Exclude future clinical-status fields from model inputs.","primary_metric":"Spearman rank correlation","secondary_metrics":["mae","rmse","top_decile_precision"]},"provenance":"forge:benchmark_seed_2026-04-28","dataset_source":{"name":"Top 100 SciDEX neurodegeneration KG entity druggability panel","labels":"0-1 composite of structure availability, ligandability, modality tractability, and target safety flags.","dataset_pointer":"scidex://forge/benchmarks/neurodegeneration-drug-target-druggability/v1/answer_key.csv","entity_selection":"Top 100 KG entities by neurodegeneration centrality and hypothesis linkage.","external_sources":["Open Targets tractability","ChEMBL ligand counts","AlphaFold/PDBe structure coverage"]},"answer_key_format":{"format":"csv","columns":{"entity_id":"SciDEX KG canonical entity or gene symbol","provenance":"Open Targets, ChEMBL, PDB, AlphaFold, PMID, or KG edge id","druggability_score":"Continuous score in [0, 1]","structural_evidence":"none|predicted|experimental","ligandability_evidence":"none|weak|moderate|strong"},"primary_key":"entity_id"},"baseline_accuracy":0.52,"baseline_performance":{"method":"Weighted sum of Open Targets tractability, ChEMBL ligand count rank, and AlphaFold high-confidence domain coverage.","primary_score":0.52,"secondary_scores":{"mae":0.18,"rmse":0.24}}},"benchmark_slug":"neurodegeneration-drug-target-druggability","canonical_path":"/forge/benchmarks/neurodegeneration-drug-target-druggability","_schema_version":1,"dataset_pointer":"scidex://forge/benchmarks/neurodegeneration-drug-target-druggability/v1/answer_key.csv","answer_key_format":{"format":"csv","columns":{"entity_id":"SciDEX KG canonical entity or gene symbol","provenance":"Open Targets, ChEMBL, PDB, AlphaFold, PMID, or KG edge id","druggability_score":"Continuous score in [0, 1]","structural_evidence":"none|predicted|experimental","ligandability_evidence":"none|weak|moderate|strong"},"primary_key":"entity_id"},"baseline_accuracy":0.52},"created_at":"2026-04-28T11:36:40.687417-07:00","updated_at":"2026-04-28T19:46:45.053531-07:00","version_number":7,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":null,"citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":null,"contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"3e6925ea-7b31-49ae-a58d-cace7818a495","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"codex:52"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"hypothesis-h-6fe30c39bc","link_type":"related","strength":0.75,"evidence":"Neurodegeneration Drug Target Druggability benchmark seeded to evaluate hypotheses/gaps related to hypothesis-h-6fe30c39bc (forge:benchmark_seed_2026-04-28)."},{"target_artifact_id":"hypothesis-h-78c49508e9","link_type":"related","strength":0.75,"evidence":"Neurodegeneration Drug Target Druggability benchmark seeded to evaluate hypotheses/gaps related to hypothesis-h-78c49508e9 (forge:benchmark_seed_2026-04-28)."},{"target_artifact_id":"gap-debate-20260417-033041-af540ce7","link_type":"targets","strength":0.75,"evidence":"Neurodegeneration Drug Target Druggability benchmark seeded to evaluate hypotheses/gaps related to gap-debate-20260417-033041-af540ce7 (forge:benchmark_seed_2026-04-28)."},{"target_artifact_id":"gap-senescent-clearance-neuro","link_type":"targets","strength":0.75,"evidence":"Neurodegeneration Drug Target Druggability benchmark seeded to evaluate hypotheses/gaps related to gap-senescent-clearance-neuro (forge:benchmark_seed_2026-04-28)."}],"incoming_links":[],"current_artifact_id":"bench_neurodegeneration_drug_target_druggability_v1","is_canonical":true,"supersede_chain":["bench_neurodegeneration_drug_target_druggability_v1"]}